Elevated protein kinase C betaII is an early promotive event in colon carcinogenesis.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Cancer Research

• Publication date

  2001-02-02

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11245437
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activation of protein kinase C modulates cell–cell and cell–substratum adhesion of a human colorectal carcinoma cell line and restores ‘normal’ epithelial morphology

  1999cited by this paper
• Overexpression of Protein Kinase C βII Induces Colonic Hyperproliferation and Increased Sensitivity to Colon Carcinogenesis

  1999cited by this paper
• Aberrant crypt foci of the colon as precursors of adenoma and cancer

  1998cited by this paper
• Insulin regulates protein kinase CbetaII expression through enhanced exon inclusion in L6 skeletal muscle cells. A novel mechanism of insulin- and insulin-like growth factor-i-induced 5' splice site selection.

  1998cited by this paper
• Protein kinase C α modulates growth and differentiation in Caco-2 cells

  1998cited by this paper
• Decreased PKC-α Expression Increases Cellular Proliferation, Decreases Differentiation, and Enhances the Transformed Phenotype of CaCo-2 Cells

  1998cited by this paper
• Decreased PKC-alpha expression increases cellular proliferation, decreases differentiation, and enhances the transformed phenotype of CaCo-2 cells.

  1998cited by this paper
• Protein kinase C alpha modulates growth and differentiation in Caco-2 cells.

  1998cited by this paper
• A novel methodological approach to study the level of specific protein and gene expression in aberrant crypt foci putative preneoplastic colonic lesions by Western blotting and RT-PCR.

  1997cited by this paper
• Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumorigenesis.

  1997cited by this paper
• Protein Kinase C Isozyme-mediated Cell Cycle Arrest Involves Induction of p21waf1/cip1 and p27kip1 and Hypophosphorylation of the Retinoblastoma Protein in Intestinal Epithelial Cells*

  1997cited by this paper
• Effects of a high-fat diet on azoxymethane-induced aberrant crypt foci and fecal biochemistry and microbial activity in rats.

  1997cited by this paper
• Dietary fat and risk of chronic disease: mechanistic insights from experimental studies.

  1997cited by this paper
• K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients.

  1997cited by this paper
• Dietary fat and colon cancer.

  1996cited by this paper
• Apoptosis, cell replication, and Western-style diet-induced tumorigenesis in mouse colon.

  1996cited by this paper
• Protein kinase C tissue localization in human colonic tumors suggests a role for adenoma growth control.

  1996cited by this paper
• Protein kinase C beta 1 and protein kinase C beta 2 activate p57 mitogen-activated protein kinase and block differentiation in colon carcinoma cells.

  1996cited by this paper
• Mechanism of Action of Chemoprotective Ursodeoxycholate in the Azoxymethane Model of Rat Colonic Carcinogenesis: Potential Roles of Protein Kinase C-α, -βII, and -ξ

  1995cited by this paper
• Localization of protein kinase C isozymes in rat colon.

  1995cited by this paper
• Expression of protein kinase C isoenzymes in colorectal cancer tissue and their differential activation by different bile acids

  1995cited by this paper
• Mechanism of action of chemoprotective ursodeoxycholate in the azoxymethane model of rat colonic carcinogenesis: potential roles of protein kinase C-alpha, -beta II, and -zeta.

  1995cited by this paper
• Role of aberrant crypt foci in understanding the pathogenesis of colon cancer.

  1995cited by this paper
• Regulation of alternative splicing of protein kinase C beta by insulin.

  1995cited by this paper
• Two Closely Related Isoforms of Protein Kinase C Produce Reciprocal Effects on the Growth of Rat Fibroblasts

  1995cited by this paper
• Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons.

  1994cited by this paper
• Expression of multiple isoforms of protein kinase C in normal human colon mucosa and colon tumors and decreased levels of protein kinase C β and η mRNAs in the tumors

  1994cited by this paper
• Protein kinase C isoforms in human and rat colonic mucosa.

  1994cited by this paper
• Five of six protein kinase C isoenzymes present in normal mucosa show reduced protein levels during tumor development in the human colon.

  1994cited by this paper
• Expression of cytokines, TNF-alpha and IL-1 alpha, in MAM acetate and 1-hydroxyanthraquinone-induced colon carcinogenesis of rats.

  1994cited by this paper
• Expression of cytokines, TNF-α and IL-1α, in MAM acetate and 1-hydroxyanthraquinone-induced colon carcinogenesis of rats

  1994cited by this paper
• K-ras mutations in putative preneoplastic lesions in human colon.

  1993cited by this paper
• Phorbol ester-induced myeloid differentiation is mediated by protein kinase C-alpha and -delta and not by protein kinase C-beta II, -epsilon, -zeta, and -eta.

  1993cited by this paper
• Dietary fibers and fats alter rat colon protein kinase C activity: correlation to cell proliferation.

  1993cited by this paper
• Protein kinase C-mediated inhibition of vascular smooth muscle cell proliferation: the isoforms that may mediate G1/S inhibition.

  1993cited by this paper
• Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid.

  1993cited by this paper
• Protein kinase C isoenzymes: divergence in signal transduction?

  1993cited by this paper
• Protein kinase C isotypes in human erythroleukemia (K562) cell proliferation and differentiation. Evidence that beta II protein kinase C is required for proliferation.

  1993cited by this paper
• Decreased levels of protein kinase C enzyme activity and protein kinase C mRNA in primary colon tumors

  1993cited by this paper
• Protein kinase C isotypes in human erythroleukemia cell proliferation and differentiation.

  1992cited by this paper
• Alterations in protein kinase C in 1,2-dimethylhydrazine induced colonic carcinogenesis.

  1992cited by this paper
• Selective translocation of beta II-protein kinase C to the nucleus of human promyelocytic (HL60) leukemia cells.

  1991cited by this paper
• Dose response and proliferative characteristics of aberrant crypt foci: putative preneoplastic lesions in rat colon.

  1991cited by this paper
• Nonmutagenic mechanisms in carcinogenesis: role of protein kinase C in signal transduction and growth control.

  1991cited by this paper
• Fecal excretion, uptake and metabolism by colon mucosa of diacylglycerol in rats.

  1991cited by this paper
• Production of diacylglycerol, an activator of protein kinase C, by human intestinal microflora.

  1990cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper
• The molecular heterogeneity of protein kinase C and its implications for cellular regulation

  1988cited by this paper
• Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings.

  1987cited by this paper
• Expression and properties of two types of protein kinase C: alternative splicing from a single gene.

  1987cited by this paper
• Predictive Value of Proliferation, Differentiation and Apoptosis as Intermediate Markers for Colon Tumorigenesis

  year unknowncited by this paper
• Protein Kinase C Isotypes in Human Erythroleukemia Cell Proliferation and Differentiation

  year unknowncited by this paper

• Protein Kinase C Family: Structures, Biological Functions, Diseases, and Pharmaceutical Interventions

  2025cites this paper
• Impact of poorly controlled type II diabetes mellitus on chemoresistance in colorectal cancer

  2025cites this paper
• Selective chemical and genetic inhibition of PKCβII strongly sensitizes colon cancer cells to anoikis

  2025cites this paper
• Sensitive fluorescent biosensor reveals differential subcellular regulation of PKC

  2024cites this paper
• Sensitive Fluorescent Biosensor Reveals Differential Subcellular Regulation of PKC

  2024cites this paper
• Protein Kinase C Life Cycle: Explained Through Systems Biology Approach

  2022cites this paper
• PKCβ Facilitates Leukemogenesis in Chronic Lymphocytic Leukaemia by Promoting Constitutive BCR-Mediated Signalling

  2022cites this paper
• Diabetes and Colorectal Cancer Risk: A New Look at Molecular Mechanisms and Potential Role of Novel Antidiabetic Agents

  2021cites this paper
• Viral Proteins as Emerging Cancer Therapeutics

  2021cites this paper
• Investigations of mouse models during tumorigenesis revealed essential but distinct in vivo functions among the PKC family.

  2020cites this paper
• Evaluating the current status of protein kinase C (PKC)-protein kinase D (PKD) Signalling Axis as a novel therapeutic target in ovarian Cancer.

  2020cites this paper
• A novel transgenic mouse strain expressing PKCβII demonstrates expansion of B1 and marginal zone B cell populations

  2020cites this paper
• Leptin, Adiponectin, and Sam68 in Bone Metastasis from Breast Cancer

  2020cites this paper
• The complexities of PKCα signaling in cancer.

  2020cites this paper
• A systems biology-based molecular model of the protein kinase C life cycle

  2019cites this paper
• Dissecting the role of lymphoid enhancer factor 1 (LEF1) in acute myeloid leukemia

  2019cites this paper
• The Oncogene Metadherin Interacts with the Known Splicing Proteins YTHDC1, Sam68 and T-STAR and Plays a Novel Role in Alternative mRNA Splicing

  2019cites this paper
• Obese rats supplemented with bitter melon display marked shifts in the expression of genes controlling inflammatory response and lipid metabolism by RNA-Seq analysis of colonic mucosa

  2018cites this paper
• Low-dose staurosporine selectively reverses BCR-ABL-independent IM resistance through PKC-α-mediated G2/M phase arrest in chronic myeloid leukaemia

  2018cites this paper
• Functional Role of Protein Kinase C Alpha in Endometrial Carcinogenesis

  2018cites this paper
• Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression.

  2017cites this paper
• Transcriptional mechanism of vascular endothelial growth factor-induced expression of protein kinase CβII in chronic lymphocytic leukaemia cells

  2017cites this paper
• Aldose Reductase Inhibitor, Fidarestat Prevents High-fat Diet-induced Intestinal Polyps in ApcMin/+ Mice.

  2017cites this paper
• Chapter 5 – Complex Glucomannan From Ganoderma atrum

  2017cites this paper
• Signaling Pathways Driving Aberrant Splicing in Cancer Cells

  2017cites this paper
• Enzastaurin: A lesson in drug development.

  2017cites this paper
• PKC-mediated phosphorylation of nuclear lamins at a single serine residue regulates interphase nuclear size in Xenopus and mammalian cells

  2017cites this paper
• Analysis of the relationship between PM2.5 and lung cancer based on protein-protein interactions.

  2016cites this paper
• A pharmacokinetic and safety study of a fixed oral dose of enzastaurin HCl in native Chinese patients with refractory solid tumors and lymphoma

  2016cites this paper
• Porcine reproductive and respiratory syndrome virus (PRRSV) up-regulates IL-15 through PKCβ1-TAK1-NF-κB signaling pathway.

  2016cites this paper
• Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy

  2016cites this paper
• Protein kinase C beta II suppresses colorectal cancer by regulating IGF-1 mediated cell survival

  2016cites this paper
• Apoptin interacts with and regulates the activity of protein kinase C beta in cancer cells

  2015cites this paper
• Anti-inflammatory Approaches for Colorectal Cancer Chemoprevention

  2015influential citation
• Generation of a poor prognostic chronic lymphocytic leukemia-like disease model: PKCα subversion induces up-regulation of PKCβII expression in B lymphocytes

  2015cites this paper
• Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemoprevention.

  2015influential citation
• Targeting Protein Kinase C Downstream of Growth Factor and Adhesion Signalling

  2015cites this paper
• Modulation of PKC signaling and induction of apoptosis through suppression of reactive oxygen species and tumor necrosis factor receptor 1 (TNFR1): key role of quercetin in cancer prevention

  2015cites this paper
• experimental diabetes cardiovascular tissues during early stages of Upregulation of PKC genes and isozymes in

  2015cites this paper
• A polysaccharide from Ganoderma atrum inhibits tumor growth by induction of apoptosis and activation of immune response in CT26-bearing mice.

  2014cites this paper
• Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer

  2014cites this paper
• Open‐label, single‐arm, phase II study of enzastaurin in patients with follicular lymphoma

  2014cites this paper
• 1 Protein kinase C ( PKC ) as a drug target in chronic lymphocytic leukemia

  2014cites this paper
• Aldose reductase inhibition suppresses azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice.

  2014cites this paper
• Signalling of Apoptin.

  2014cites this paper
• Randomised controlled trial of the effects of fish oil emulsion in total parenteral nutrition upon tumour vascularity in patients with hepatic colorectal metastases

  2014cites this paper
• MicroRNA-2023 p Inhibits Cell Proliferation by Targeting ADP-Ribosylation Factor-like 5 A in Human Colorectal Carcinoma

  2014cites this paper
• Genomewide RNAi screen identifies protein kinase Cβ and new members of mitogen‐activated protein kinase pathway as regulators of melanoma cell growth and metastasis

  2014cites this paper
• Role of calcium-dependent protein kinases in chronic myeloid leukemia: combined effects of PKC and BCR-ABL signaling on cellular alterations during leukemia development

  2014cites this paper
• (LY317615.HCl) novel, orally available small-molecule inhibitor enzastaurin Targeting PKC in multiple myeloma: in vitro and in vivo effects of the

  2013cites this paper
• MicroRNA-202-3p Inhibits Cell Proliferation by Targeting ADP-Ribosylation Factor-like 5A in Human Colorectal Carcinoma

  2013cites this paper
• Modulation of Pancreatic Tumor Potential by Overexpression of Protein Kinase C &bgr;1

  2013cites this paper
• The Multifaceted Effects of Omega-3 Polyunsaturated Fatty Acids on the Hallmarks of Cancer

  2013cites this paper
• Protein kinase C (PKC) as a drug target in chronic lymphocytic leukemia

  2013cites this paper
• Protein Kinase C Delta Negatively Modulates Canonical Wnt Pathway and Cell Proliferation in Colon Tumor Cell Lines

  2013cites this paper
• The Protein Kinase C Inhibitor Enzastaurin Exhibits Antitumor Activity against Uveal Melanoma

  2012cites this paper
• Delineation of molecular events that occur in a PKCα-KR-mediated murine model of CLL

  2012cites this paper
• High nuclear protein kinase CβII expression is a marker of disease recurrence in oral squamous cell carcinoma.

  2012cites this paper
• C 1 B domain peptide of protein kinase C γ significantly suppresses growth of human colon cancer cells in vitro and in an in vivo mouse xenograft model through induction of cell cycle arrest and apoptosis

  2012cites this paper
• A phase II study of enzastaurin in combination with erlotinib in patients with previously treated advanced non-small cell lung cancer.

  2012cites this paper
• MOAP-1: A Candidate Tumor Suppressor Protein

  2012cites this paper
• Prox1 overexpression of Hela cells inhibits PKC beta II transcription through promoter DNA methylation

  2012cites this paper
• C1B domain peptide of protein kinase Cγ significantly suppresses growth of human colon cancer cells in vitro and in an in vivo mouse xenograft model through induction of cell cycle arrest and apoptosis

  2012cites this paper
• Lack of Protein Kinase C alpha is associated with poor prognosis in pediatric T-ALL: a phosphoproteomic discovery

  2012cites this paper
• Ellagic acid checks lymphoma promotion via regulation of PKC signaling pathway

  2012cites this paper
• PROX1 overexpression inhibits protein kinase C beta II transcription through promoter DNA methylation

  2012cites this paper
• EGF Regulation of HRPAP20: A Role for Calmodulin and Protein Kinase C in Breast Cancer Cells

  2011cites this paper
• Protein Kinase C: An Attractive Target for Cancer Therapy

  2011cites this paper
• Importance of PKCδ signaling in fractionated-radiation-induced expansion of glioma-initiating cells and resistance to cancer treatment

  2011cites this paper
• The Protein Kinase C Family: Key Regulators Bridging Signaling Pathways in Skin and Tumor Epithelia

  2011cites this paper
• Protein kinase C ζ is a positive modulator of canonical Wnt signaling pathway in tumoral colon cell lines.

  2011cites this paper
• Protein kinase C in Wnt signaling: Implications in cancer initiation and progression

  2011cites this paper
• Targeting PKC‐β II and PKB Connection: Design of Dual Inhibitors

  2011cites this paper
• A novel bisindolymaleimide derivative (WK234) inhibits proliferation and induces apoptosis through the protein kinase Cβ pathway, in chronic myelogenous leukemia K562 cells

  2011cites this paper
• Over-expression of protein kinase C isoforms (α, δ, θ and ζ) in squamous cervical cancer.

  2011cites this paper
• Apple nutraceuticals and the effects of processing, and their therapeutic applications.: Apple nutraceuticals and the effects of processing, and their therapeutic applications.

  2011cites this paper
• Cell signaling and neurotoxicity: protein kinase C in vitro and in vivo.

  2011cites this paper
• Impact of Obesity and Leptin on Protein Expression Profiles in Mouse Colon

  2011cites this paper
• Investigating the Therapeutic Efficacy of a Novel Inhibitor GAP-107B8 on Ovarian Cancer Cells

  2011cites this paper
• Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer

  2011cites this paper
• Genetically encoded fluorescent reporters to visualize protein kinase C activation in live cells.

  2011cites this paper
• The pros and cons of targeting protein kinase C (PKC) in the management of cancer patients.

  2011cites this paper
• Antitumor activity of enzastaurin as radiation sensitizer in head and neck squamous cell carcinoma

  2011cites this paper
• Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells

  2011cites this paper
• A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies.

  2011cites this paper
• Papel de los ácidos grasos omega 3 en la prevención del cáncer de colon

  2011cites this paper
• Atypical PKCs as Targets for Cancer Therapy

  2010cites this paper
• Efficacy of the Multi-Kinase Inhibitor Enzastaurin Is Dependent on Cellular Signaling Context

  2010cites this paper
• Dietary omega-3 polyunsaturated fatty acids and cancer

  2010cites this paper
• ω-3 PUFAs and Colon Cancer: Experimental Studies and Human Interventional Trials

  2010cites this paper
• Expression of Protein Kinase C Family in Human Hepatocellular Carcinoma

  2010cites this paper
• Hydrophobic protein in colorectal cancer in relation to tumor stages and grades.

  2010cites this paper
• Randomized, Double-Blinded, Multicenter, Phase II Study of Pemetrexed, Carboplatin, and Bevacizumab with Enzastaurin or Placebo in Chemonaïve Patients with Stage IIIB/IV Non-small Cell Lung Cancer: Hoosier Oncology Group LUN06-116

  2010cites this paper
• Enzastaurin inhibits invasion and metastasis in lung cancer by diverse molecules

  2010cites this paper
• PKC and the Control of Apoptosis

  2010cites this paper
• A Phase I Study of Enzastaurin Combined with Pemetrexed in Advanced Non-small Cell Lung Cancer

  2010cites this paper
• A window of opportunity phase II study of enzastaurin in chemonaive patients with asymptomatic metastatic colorectal cancer.

  2010cites this paper
• Epithelial-to-Mesenchymal Transition and Oncogenic Ras Expression in Resistance to the Protein Kinase Cβ Inhibitor Enzastaurin in Colon Cancer Cells

  2010cites this paper
• Enzastaurin (LY317615), a protein kinase C beta selective inhibitor, enhances antiangiogenic effect of radiation.

  2010cites this paper
• Exploitation of protein kinase C: a useful target for cancer therapy.

  2009cites this paper